{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:15:01Z","timestamp":1788498901294,"version":"build-2803163510"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Synchronous dual-primary esophageal and gastric cancers (SEGC) are rare upper gastrointestinal malignancies presenting substantial challenges for prognostic assessment and individualized clinical evaluation. Conventional single-organ staging systems inadequately capture the cumulative tumor burden of synchronous cancers, limiting accurate prognostic assessment when tumors with different extents coexist. This study aimed to develop and externally validate a prognostic nomogram incorporating a Combined EG_Stage framework for exploratory risk stratification and post-treatment prognostic counseling in actively treated SEGC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective development cohort was assembled from a high-volume tertiary cancer center over 10 years (n = 46), with overall survival (OS) as the primary endpoint. A simplified Combined EG_Stage framework was developed to characterize cumulative anatomical tumor extent. Candidate prognostic predictors included age, treatment modality, and Combined EG_Stage. A multivariable Cox proportional hazards model was used to construct the nomogram. External validation used an independent cohort identified from 6,896 patients with multiple primary malignancies in the Surveillance, Epidemiology, and End Results (SEER) database, yielding 88 eligible patients. Model performance was assessed by discrimination, calibration, risk stratification, and decision curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The final nomogram incorporated age, treatment modality, and Combined EG_Stage. Internal validation demonstrated satisfactory calibration across 1-, 3-, and 5-year horizons. In the external cohort, the model achieved a C-index of 0.681, with time-dependent AUC values of 0.616, 0.674, and 0.640 for 1-, 3-, and 5-year OS. Risk stratification significantly differentiated survival outcomes (median OS: 41 vs. 22 months;\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.022). Decision curve analysis suggested limited and exploratory net benefit across selected threshold probabilities, which should be interpreted cautiously given the small sample size.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study developed and externally evaluated a clinically interpretable but modestly discriminative prognostic nomogram for actively treated SEGC patients. By integrating age, treatment modality as a real-world prognostic indicator, and combined anatomical tumor burden, the model may support exploratory risk stratification in this rare malignancy. Given the limited sample size and only modest discriminative performance, the model should be considered hypothesis-generating rather than definitive, and further multicenter validation is required to assess its robustness and generalizability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1890564","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:24:17Z","timestamp":1788495857000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A combined tumor burden\u2013based nomogram for synchronous esophageal and gastric cancers: development and external validation"],"prefix":"10.3389","volume":"16","author":[{"given":"Meng","family":"Xie","sequence":"first","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Endoscopy Center, Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Endoscopy Center, Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Jia","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ji","sequence":"additional","affiliation":[{"name":"Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education\/Beijing), Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Endoscopy Center, Peking University Cancer Hospital & Institute","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12876-020-01517-3","article-title":"Initial results from a multi-center population-based cluster randomized trial of esophageal and gastric cancer screening in China","volume":"20","author":"Zeng","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12916-024-03594-7","article-title":"The spatiotemporal associations between esophageal and gastric cancers provide evidence for its joint endoscopic screening in China: a population-based study","volume":"22","author":"Li","year":"2024","journal-title":"BMC Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301647","article-title":"Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group","volume":"62","author":"Kato","year":"2013","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1055\/a-1104-5245","article-title":"Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement","volume":"52","author":"Saftoiu","year":"2020","journal-title":"Endoscopy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7150\/jca.25482","article-title":"Multiple primary Malignant tumors - A clinical analysis of 15,321 patients with Malignancies at a single center in China","volume":"9","author":"Zhai","year":"2018","journal-title":"J Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i26.3438","article-title":"Synchronous resection of esophageal cancer and other organ Malignancies: A systematic review","volume":"25","author":"Papaconstantinou","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/acs.2017.03.14","article-title":"8th edition AJCC\/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice","volume":"6","author":"Rice","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.109624","article-title":"Synchronous carcinomas of the esophagus: Influence of prognosis and staging","volume":"51","author":"Lv","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000002118","article-title":"Clinical and prognostic features of patients with esophageal cancer and multiple primary cancers: A retrospective single-institution study","volume":"267","author":"Baba","year":"2018","journal-title":"Ann Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10388-021-00856-8","article-title":"The characteristics and prognostic significance of esophageal squamous cell carcinoma with synchronous multiple lesions: over 10-year experience","volume":"18","author":"Chen","year":"2021","journal-title":"Esophagus"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-022-01870-y","article-title":"Second primary Malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502","volume":"57","author":"Mitani","year":"2022","journal-title":"J Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2014.182","article-title":"Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome","volume":"31","author":"Lee","year":"2016","journal-title":"Korean J Intern Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110480","article-title":"Surgical treatment in synchronous oesophageal cancers - A systematic review on survival outcomes","volume":"51","author":"Bartin","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B15","article-title":"Multiple primary Malignant tumors: a surveyof the literature and a statistical study","volume":"16","author":"Warren","year":"1932","journal-title":"Am J Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-272","article-title":"Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study","volume":"14","author":"Coyte","year":"2014","journal-title":"BMC Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61111962","article-title":"Synchronous versus metachronous multiple Malignant tumors involving the digestive tract: Predictors of survival from a single-center retrospective study","volume":"61","author":"Oprita","year":"2025","journal-title":"Med (Kaunas)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12540","article-title":"Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC\/UICC staging manuals","volume":"29","author":"Rice","year":"2016","journal-title":"Dis Esophagus"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1524439","article-title":"A nomogram for predicting cancer-specific survival in patients with locally advanced unresectable esophageal cancer: development and validation study","volume":"16","author":"Xie","year":"2025","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/srep13335","article-title":"Synchronous primary esophageal squamous cell carcinoma and gastric adenocarcinoma: analysis of 41 cases treated in a single institution","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5009\/gnl13255","article-title":"Endoscopic resection for synchronous esophageal squamous cell carcinoma and gastric adenocarcinoma in early stage is a possible alternative to surgery","volume":"9","author":"Park","year":"2015","journal-title":"Gut Liver"},{"key":"B22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40792-015-0018-4","article-title":"Minimally invasive resection of synchronous thoracic esophageal and gastric carcinomas followed by reconstruction: a case report","volume":"1","author":"Honda","year":"2015","journal-title":"Surg Case Rep"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25027","article-title":"High incidence of other primary Malignancies in patients with synchronous multiple gastric cancers \"a multi-center retrospective cohort study","volume":"9","author":"Takeuchi","year":"2018","journal-title":"Oncotarget"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/srep26684","article-title":"Clinical nomogram for predicting survival of esophageal cancer patients after esophagectomy","volume":"6","author":"Cao","year":"2016","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7150\/jca.40767","article-title":"Development and validation of an individualized nomogram for predicting survival in patients with esophageal carcinoma after resection","volume":"11","author":"Du","year":"2020","journal-title":"J Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1132423","article-title":"Survival and prognostic factors in patients with synchronous multiple primary esophageal squamous cell carcinoma receiving definitive radiotherapy: A propensity score-matched analysis","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i41.7154","article-title":"Characteristics and prognosis of synchronous multiple early gastric cancer","volume":"19","author":"Isobe","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1007176","article-title":"Multi-institutional development and validation of a nomogram to predict prognosis of early-onset gastric cancer patients","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2433685","article-title":"Nomograms for predicting the prognosis in multiple primary esophageal squamous cell carcinoma","volume":"56","author":"Wang","year":"2024","journal-title":"Ann Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1186\/s12885-022-10283-2","article-title":"Comparison of clinicopathological features and prognostic significance between synchronous multiple primary and solitary esophageal squamous cell carcinomas","volume":"22","author":"Yang","year":"2022","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2017.280","article-title":"Clinical analysis of 117 cases with synchronous multiple primary esophageal squamous cell carcinomas","volume":"36","author":"Chen","year":"2021","journal-title":"Korean J Intern Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03576-4","article-title":"A prognostic nomogram to predict the cancer-specific survival of patients with initially diagnosed metastatic gastric cancer: a validation study in a Chinese cohort","volume":"27","author":"Zhao","year":"2025","journal-title":"Clin Transl Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1890564\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:24:19Z","timestamp":1788495859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1890564\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":32,"alternative-id":["10.3389\/fonc.2026.1890564"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1890564","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1890564"}}